Follow the Shilpa Medicare Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Shilpa Medicare Limited has published 33 reports. Market capitalisation: €119.5bn. The latest transaction was disclosed on 12 December 2024 (Sale). Among the most active insiders: DEEPAK KUMAR INNANI. The full history is free.
33
Insider Decl.
n/a
Thresholds
€12,639
5 ops.
Buy Volume
€1m
8 ops.
Sell Volume
10Σ signal
Buys €12,639€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,713 of 28,685 companies
53.1
score / 100
Value
33
Quality
73
FCF yld-0.2%
Earn yld2.0%
EV/EBITDA23.6x
ROE9.8%
Gross mgn70%
Net mgn16%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,000,000 shares@ ₹271.6578.3% of flowEquity SharesSEBI:68f81b8415c0d536642cb658aaac13a5c891ffd2
25 of 33 declarations
About Shilpa Medicare Limited
Shilpa Medicare Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and biopharmaceutical products. It focuses on the development of treatments for cancer and other complex diseases.